10,000 flemish adults to be screened for silent liver disease
NCT ID NCT04647409
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find out how common non-alcoholic fatty liver disease (NAFLD) is among adults in Flanders, Belgium. Researchers will screen 10,000 people at their general practitioner's office using questionnaires and quality-of-life surveys. The goal is to gather data on disease prevalence and severity to improve future referral and care strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide the first reliable data on how many people in Flanders have NAFLD, helping doctors and health officials plan better screening and care.
- What could go wrong
- This is an observational screening study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hasselt University
Hasselt, 3500, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a scan replace the needle? ultrasound and MRI put to the test against liver biopsy for fatty liver disease
- Can fish oil shrink a fatty liver?
- Could donating blood help control diabetes and fatty liver?
- Could a diabetes drug reverse liver scarring?
- Blood test and AI could spot liver cancer early, saving lives
- New blood test may sharpen diagnosis of autoimmune liver disease